WESTFIELD CAPITAL MANAGEMENT CO LP – Neurocrine Biosciences, Inc. Transaction History
WESTFIELD CAPITAL MANAGEMENT CO LP portfolio value:
$48.87M
portfolio value
WESTFIELD CAPITAL MANAGEMENT CO LP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -12.98% | -68.66K shares | -2.67M | $106.21 | 460.18K |
Q2 2022 | share | Decrease | -4.63% | -25.64K shares | -432K | $97.48 | 528.84K |
Q1 2022 | share | Decrease | -21.49% | -151.73K shares | -8.16M | $93.75 | 554.49K |
Q4 2021 | share | Decrease | -2.34% | -16.95K shares | -9.21M | $84.63 | 706.22K |
Q3 2021 | share | Increase | +17.59% | 108.18K shares | 9.50M | $95.91 | 723.17K |
Q2 2021 | share | Increase | +14.68% | 78.74K shares | 7.70M | $97.32 | 614.99K |
Q1 2021 | share | Increase | +15.55% | 72.16K shares | 7.66M | $97.25 | 536.25K |
Q4 2020 | share | Increase | +14.80% | 59.83K shares | 5.61M | $95.85 | 464.08K |
Q3 2020 | share | Increase | +1.20% | 4.78K shares | -9.86M | $96.16 | 404.25K |
Q2 2020 | share | Decrease | -38.37% | -248.69K shares | -7.36M | $122 | 399.46K |
Q1 2020 | share | Increase | 0.00% | 648.15K shares | 56.09M | $86.55 | 648.15K |
Q2 2019 | share | Decrease | -100.00% | -316.54K shares | -27.88M | $84.43 | 0 |
Q1 2019 | share | Increase | +120.22% | 172.8K shares | 17.62M | $88.1 | 316.54K |
Q4 2018 | share | Increase | 0.00% | 143.74K shares | 10.26M | $71.41 | 143.74K |
Q3 2018 | share | Decrease | -100.00% | -184.74K shares | -18.14M | $122.95 | 0 |
Q2 2018 | share | Increase | 0.00% | 184.74K shares | 18.14M | $98.24 | 184.74K |
Q4 2017 | share | Decrease | -100.00% | -383.09K shares | -23.47M | $77.59 | 0 |
Q3 2017 | share | Decrease | -72.65% | -1.01M shares | -40.95M | $61.28 | 383.09K |
Q2 2017 | share | Increase | +18.14% | 215.10K shares | 13.09M | $46 | 1.40M |
Q1 2017 | share | Decrease | -14.93% | -208.02K shares | -2.59M | $43.3 | 1.18M |
Q4 2016 | share | Increase | +10.95% | 137.51K shares | -9.67M | $38.7 | 1.39M |
Q3 2016 | share | Decrease | -1.53% | -19.58K shares | 5.62M | $50.64 | 1.25M |
Q2 2016 | share | Decrease | -3.26% | -42.92K shares | 5.82M | $45.45 | 1.27M |
Q1 2016 | share | Increase | +7.93% | 96.85K shares | -16.96M | $39.55 | 1.31M |